Please use this identifier to cite or link to this item:
|Title:||Prevention of Ovarian Hyperstimulation Syndrome: A Review.|
|Affiliation:||Alice Springs Hospital, Department of Obstetrics and Gynaecology, Alice Springs, NT 0870, Australia..|
Monash IVF, 252 Clayton Road, Clayton, VIC 3168, Australia..
Monash IVF, 252 Clayton Road, Clayton, VIC 3168, Australia ; Monash Health, Women's and Children's Program, Monash Medical Centre, Clayton Road, Clayton, VIC 3168, Australia ; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC 3168, Australia..
|Citation:||Obstetrics and gynecology international 2015; 2015: 514159|
|Abstract:||The following review aims to examine the available evidence to guide best practice in preventing ovarian hyperstimulation syndrome (OHSS). As it stands, there is no single method to completely prevent OHSS. There seems to be a benefit, however, in categorizing women based on their risk of OHSS and individualizing treatments to curtail their chances of developing the syndrome. At present, both Anti-Müllerian Hormone and the antral follicle count seem to be promising in this regard. Both available and upcoming therapies are also reviewed to give a broad perspective to clinicians with regard to management options. At present, we recommend the use of a "step-up" regimen for ovulation induction, adjunct metformin utilization, utilizing a GnRH agonist as an ovulation trigger, and cabergoline usage. A summary of recommendations is also made available for ease of clinical application. In addition, areas for potential research are also identified where relevant.|
|Appears in Collections:||NT Health digital library|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.